ClearPoint Neuro, Inc. (CLPT)

NCM – Real vaqt narxi. Valyuta: USD

12.64

+0.33 (2.68%)

Yopilishda: May 12, 2026, 4:00 PM EDT

12.85

+0.21 (1.66%)

Bozor oldidan: May 13, 2026, 6:09 AM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

ClearPoint Neuro, Inc. (CLPT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Videolar

No Data

Press-relizlar

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

Search stocks

ClearPoint Neuro, Inc. (CLPT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Videolar

No Data

Press-relizlar

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe